Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
Ann Intern Med
    April 2025
  1. ZAR FA
    In men and gender-diverse persons, twice-yearly subcutaneous lenacapavir vs. daily oral F/TDF reduced HIV incidence.
    Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00552.
    >> Share

    October 2024
  2. MAKI DG
    In adults with postacute sequelae of COVID-19, nirmatrelvir-ritonavir did not improve symptoms at 10 wk.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02172.
    >> Share

    February 2024

  3. Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy.
    Ann Intern Med. 2024 Feb 20. doi: 10.7326/L24-0045.
    >> Share

    January 2024
  4. CHAGLA Z
    In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0108.
    >> Share

  5. CENTOR RM, Cohen MS
    Annals On Call - COVID-19 Rebound After Nirmatrelvir-Ritonavir Treatment.
    Ann Intern Med. 2024;177:eA230002.
    >> Share

    November 2023
  6. COHEN MS, Brown ER
    Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy.
    Ann Intern Med. 2023 Nov 14. doi: 10.7326/M23-2887.
    >> Share

  7. EDELSTEIN GE, Boucau J, Uddin R, Marino C, et al
    SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.
    Ann Intern Med. 2023 Nov 14. doi: 10.7326/M23-1756.
    >> Share

    October 2023
  8. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.
    Ann Intern Med. 2023 Oct 31. doi: 10.7326/M23-1394.
    >> Share

  9. FOCOSI D, Nicastri E
    Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19.
    Ann Intern Med. 2023;176:eL230264.
    >> Share

  10. WAN EYF, Yan VKC, Mok AHY, Wong ICK, et al
    Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19.
    Ann Intern Med. 2023;176:eL230265.
    >> Share

    September 2023
  11. SOMMER I, Ledinger D, Thaler K, Dobrescu A, et al
    Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2).
    Ann Intern Med. 2023 Sep 19. doi: 10.7326/M23-1626.
    >> Share

  12. QASEEM A, Yost J, Abraham GM, Andrews R, et al
    Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2).
    Ann Intern Med. 2023 Sep 19. doi: 10.7326/M23-1636.
    >> Share

    June 2023
  13. BAJEMA KL, Berry K, Streja E, Rajeevan N, et al
    Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes.
    Ann Intern Med. 2023 Jun 6:M22-3565. doi: 10.7326/M22-3565.
    >> Share

    March 2023
  14. HERNAN MA, Del Amo J
    Drug Repurposing and Observational Studies: The Case of Antivirals for the Treatment of COVID-19.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M22-3582.
    >> Share

  15. WAN EYF, Yan VKC, Mok AHY, Wang B, et al
    Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study.
    Ann Intern Med. 2023 Mar 14. doi: 10.7326/M22-3057.
    >> Share

    February 2023
  16. DEO R, Choudhary MC, Moser C, Ritz J, et al
    Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
    Ann Intern Med. 2023 Feb 21. doi: 10.7326/M22-2381.
    >> Share

    December 2022
  17. DRYDEN-PETERSON S, Kim A, Kim AY, Caniglia EC, et al
    Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/M22-2141.
    >> Share

  18. ANESI GL, Maguire C
    Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/M22-3427.
    >> Share

    November 2022
  19. QASEEM A, Yost J, Miller MC, Andrews R, et al
    Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1).
    Ann Intern Med. 2022 Nov 29. doi: 10.7326/M22-2249.
    >> Share

  20. SOMMER I, Dobrescu A, Ledinger D, Moser I, et al
    Outpatient Treatment of Confirmed COVID-19 : A Living, Rapid Review for the American College of Physicians.
    Ann Intern Med. 2022 Nov 29. doi: 10.7326/M22-2202.
    >> Share

    June 2022
  21. VASSILOPOULOS A, Mylonakis E
    In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0038.
    >> Share

    March 2022
  22. MARZOLINI C, Kuritzkes DR, Marra F, Boyle A, et al
    Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/M22-0281.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016